Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.9B | 6.4B | 5.5B | 5.4B |
| Cost of revenue | 2.1B | 2.3B | 2.0B | 2.0B |
| Gross profit | 3.7B | 4.2B | 3.5B | 3.4B |
| Operating expense | ||||
| Research & development | 405M | 358M | 377M | 363M |
| Selling general and admin | 2.3B | 2.1B | 1.9B | 1.8B |
| Other operating expenses | — | — | — | — |
| Operating income | 872M | 1.6B | 1.1B | 1.1B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | -108M | -1.0B | -42M | -53M |
| Pretax income | 764M | 528M | 1.0B | 998M |
| Tax provision | 110M | -18M | 209M | 173M |
| Net income | 654M | 546M | 834M | 825M |
| Basic EPS | 1.7 | 1.4 | 2.2 | 2.2 |
| Diluted EPS | 1.7 | 1.4 | 2.2 | 2.1 |
| Basic average shares | 381.7M | 381.3M | 381.1M | 381M |
| Diluted average shares | 386.4M | 386.1M | 385.6M | 385.4M |
| EBITDA | 1.2B | 1.8B | 1.4B | 1.3B |
| Net income from continuing op. | 654M | 546M | 834M | 825M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |